Suppression of endogenous IL-10 gene expression in dendritic cells enhances antigen presentation for specific Th1 induction: Potential for cellular vaccine development

Journal of Immunology

Volumn 164, Issue 8, 2000, Pages 4212-4219

  Igietseme, Joseph U ^a   Ananaba, Godwin A ^b   Bolier, Jacqueline ^a   Bowers, Samera ^b   Moore, Terri ^a   Belay, Tesfaye ^a   Eko, Francis O ^a   Deborah, Lyn ^a   Black, Carolyn M ^c  

^a MOREHOUSE SCHOOL OF MEDICINE   (United States)

^b SPELMAN COLLEGE   (United States)

^c NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; VACCINE;

ADOPTIVE IMMUNOTHERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ARTICLE; CHLAMYDIA TRACHOMATIS; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; GENE EXPRESSION; GENE INDUCTION; IMMUNE RESPONSE; IMMUNITY; IMMUNOMODULATION; IMMUNOREGULATION; INFECTION RESISTANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0034655214     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.8.4212     Document Type: Article

References (54)

1. WHO. 1996. Global Prevalence and Incidence of Selected Curable Sexually Transmitted Diseases: Overview and Estimates. World Health Organization, Geneva.
2. Schachter, J., and J. T. Grayston. 1998. Epidemiology of human chlamydial infections. In Chlamydial Infections. R. S. Stephens, G. I. Byrne, G. Christiansen, I. N. Clarke, J. T. Grayston, R. G. Rank, G. L. Ridgway, P. Saikku, J. Schachter, and W. E. Stamm, eds. ICS, San Francisco, p. 3.
3. CDC, and PHS. 1997. Chlamydia trachomatis genital infections-United States, 1995. Morbid. Mortal. Wkly. Rep. 46:193.
4. Paavonen, J., and P. Wolner-Hanssen. 1989. Chlamydia trachomatis: a major threat to reproduction. J. Hum. Reprod. 4:111.
5. Scholes, D., A. Stergachis, F. E. Heidrich, H. Andrilla, K. K. Holmes, and W. E. Stamm. 1996. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. M Engl. J. Med. 334:1362.
6. Stagg, A. J., M. Tuffrey, C. Woods, E. Wunderink, and S. C. Knight. 1998. Protection against ascending infection of the genital tract by Chlamydia trachomatis is associated with recruitment of major histocompatibility complex class II antigen-presenting cells into uterine tissue. Infect. Immun. 66:3535.
7. Igietseme, J. U., I. M. Uriri, S. N. Kumar, G. A. Ananaba, O. O. Ojior, I. A. Momodu, D. H. Candal, and C. M. Black. 1998. Route of infection that induces a high intensity of γ interferon-secreting T cells in the genital tract produces optimal protection against Chlamydia trachomatis infection in mice. Infect. Immun. 66:4030.
8. Patton, D. L., and R. G. Rank. 1992. Animal models for the study of pelvic inflammatory disease. In Sexually Transmitted Diseases. T. C. Quinn, ed. Raven Press, New York, p. 85.
9. Cain, T. K., and R. G. Rank. 1995. Local Th1-like responses are induced by intravaginal infection of mice with the mouse pneumonitis (MoPn) biovar of Chlamydia trachomatis. Infect. Immun. 63:1784.
10. Johansson, M., K. Schon, M. Ward, and N. Lycke. 1997. Studies in knockout mice reveal that anti-chlamydial protection requires TH1 cells producing IFN-γ: is this true for human? Scand. J. Immunol. 46:546.
11. Rasmusen, S. 1998. Chlamydia immunity. Curr. Opin. Infect. Dis. 11:37.
12. Byrne, G. I. 1998. Immunity to Chlamydia. In Chlamydial Infections. R. S. Stephens, G. I. Byrne, G. Christainsen, I. N. Clarke, J. T. Grayston, R. G. Rank, G. L. Ridgway, P. Saikku, J. Schachter, and W. E. Stamm, eds. ICS, San Francisco, p. 365.
13. Igietseme, J. U., K. H. Ramsey, D. M. Magee, D. M. Williams, T. J. Kincy, and R. G. Rank. 1993. Resolution of murine chlamydial genital infection by the adoptive transfer of a biovar-specific, Th1 lymphocyte clone. Regional Immunol. 5:317.
14. Cotter, T. W., K. H. Ramsey, G. S. Miranpuri, C. E. Poulsen. and G. I. Byrne. 1997. Dissemination of Chlamydia trachomatis chronic genital tract infection in γ interferon gene knockout mice. Infect. Immun. 65:2145.
15. Johansson, M., K. Schon, M. Ward, and N. Lycke. 1997. Genital tract infection with Chlamydia trachomatis fails to induce protective immunity in γ interferon receptor-deficient mice despite a strong local immunoglobulin A response. Infect. Immun. 65:1032.
16. + T cells play a significant role in adoptive immunity to Chlamydia trachomatis infection of the mouse genital tract. Infect. Immun. 63:3302.
17. Hynes, R. O. 1992. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69:11.
18. Hunkapillar, T., and L. Hood. 1989. Diversity of the immunoglobulin gene superfamily. Adv. Immunol. 44:1.
19. Fresno, M., M. Kopf, and L. Rivas, 1997. Cytokines and infectious diseases. Immunol. Today 18:56.
20. + T cell subsets. Immunol. Rev. 123:5.
21. Moore, K. W., A. O'Garra, R. d. W. Malefyt, P. Vieira, and T. R. Mosmann. 1993. Interleukin-10. Annu. Rev. Immunol. 11:165
22. Yang, X., K. T. HayGlass, and R. C. Brunham. 1996. Genetically determined differences in IL-10 and IFN-γ responses correlate with clearance of Chlamydia trachomatis mouse pneumonitis infection. J. Immunol. 156:4338.
23. Cohen, C. R., F. A. Plummer, N. Mugo, I. Maclean, C. Shen, E. A. Bukusi, E. Irungu, S. Sinei, J. Bwayo, and R. C. Brunham 1999. Increased interleukin-10 in the endocervical secretions of women with non-ulcerative sexually transmitted diseases: a mechanism for enhanced HIV-1 transmission? AIDS 25:327.
24. Fierer, J., L. Walls, L. Eckmann, T. Yamamoto, and T. N. Kirkland. 1998. Importance of interleukin-10 in genetic susceptibility of mice to Coccidioides immitis. Infect. Immun. 66:4397.
25. Ramsey, K. H., L. S. F. Soderberg, and R. G. Rank. 1988. Resolution of chlamydial genital infection in B-cell-deficient mice and immunity to reinfection. Infect. Immun. 56:1320.
26. Kees, U., G. Kynast, E. Weber, and P. H. Krammer. 1984. A method for testing the specificity of influenza A virus-reactive memory cytotoxic T lymphocytes (CTL) clones in limiting dilution cultures. J. Immunol. Methods 69:215.
27. Krammer, P. H., M. Dy, L. Hultner, P. Isakson, U. Kees, M.-L. Lohmann-Matthes, F. Marcucci, A. Michnay, E. Pure, A. Schimpl, et al. 1982. Production of lymphokines by murine T cells grown in limiting dilution and long-term cultures. In Isolation, Characterization, and Utilization of T Lymphocyte Clones. C. G. Fathman and F. W. Fitch, eds. Academic Press, New York, p. 252.
28. Igietseme, J. U., and R. G. Rank. 1991. Susceptibility to reinfection after a primary chlamydial genital infection is associated with a decrease of antigen-specific T cells in the genital tract. Infect. Immun. 59:1346.
29. Su, H., R. Messer, W. Whitmire, E. Fischer, J. C. Portis, and H. D. Caldwell. 1998. Vaccination against chlamydial genital tract infection after immunization with dendritic cells pulsed ex vivo with nonviable chlamydiae. J. Exp. Med. 188:809.
30. Moore, K. W., P. Vieira, D. F. Fiorentino, M. L. Trounstine, T. A. Khan, and T. R. Mosmann. 1990. Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus BCRFI. Science 248:1230.
31. + B (B-I) cells by antisense IL-10 oligonucleotide. Leukemia Res. 19:169.
32. Ramsey, K. H., W. J. Newhall, and R. G. Rank. 1989. Humoral immune response to chlamydial genital infection of mice with the agent of mouse pneumonitis. Infect. Immun. 57:2441.
33. Trinchieri, G. 1993. Interleukin-12 and its role in the generation of TH1 cells. Immunol Today 14:335.
34. Williams, D. M., B. G. Grubbs, T. Darville, K. Kelly, and R. G. Rank. 1998. A role for interleukin-6 in host defense against murine Chlamydia trachomatis infection. Infect. Infect. 66:4564.
35. Su, H., and H. D. Caldwell. 1995. Kinetics of chlamydial antigen processing and presentation to T cells by paraformaldehyde-fixed murine bone marrow-derived macrophages. Infect. Immun. 63:946.
36. Perry, L. L., H. Su, K. Feilzer, R. Messer, S. Hughes, W. Whitmire, and H. D. Caldwell. 1999. Differential sensitivity of distinct Chlamydia trachomatis isolates to IFN-γ-mediated inhibition. J. Immunol. 162:3541.
37. Yang, X., and R. C. Brunham. 1998. Role of T cell-mediated immunity in host defense against Chlamydia trachomatis and its implication for vaccine development. Can. J. Infect. Dis. 9:99.
38. Yang, X., J. Gartner, L. Zhu, S. Wang, and R. C. Brunham. 1999. IL-10 gene knockout mice show enhanced Th1-like protective immunity and absent granuloma formation following Chlamydia trachomatis lung infection. J. Immunol. 162:1010.
39. Fiorentino, D. F., A. Zlotnik, P. Vieira, T. R. Mosmann, M. Howard, K. W. Moore, and A. O'Garra. 1991. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J. Immunol. 146:3444.
40. Ding, L., P. S. Linsley, Y. Huang, R. N. Germain, and E. M. Shevach. 1993. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J. Immunol. 151:1224.
41. Steinman, R, M. 1991. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9:271.
42. Gilboa, E., S. K. Nair, and H. K. Lyerly. 1998. Immunotherapy of cancer with dendritic-cell-based vaccines. Cancer Immunol. Immunother. 46:82.
43. Bartholeyns, J., J. L. Romet-Lemonne, M. Chokri, M. Buyse, T. Velu, C. Bruyns, J. J. Van de Winkel, J. Heeney, G. Koopman, M. Malmsten, et al. 1998. Cellular vaccines. Res. Immunol. 149:647.
44. Jenkins, M. K . D. R. DeSilvia, J. G. Johnson, and S. D. Norton. 1999. 5th International Symposium on Dendritic Cells in Fundamental and Clinical Immunology, Pittsburgh, PA, September 23-28, 1999. J. Leukocyte Biol. 2(Suppl.):11.
45. Caloco, C. A. L. S. 1999. Why are dendritic cells central to cancer immunotherapy? Mol. Med. Today 5:14.
46. Reid, C. D. L. 1998. The biology and clinical applications of dendritic cells. Transf. Med. 8:77.
47. + T cells. J. Immunol. 154:5071.
48. Heufler, C., F. Koch, U. Stanzl, G. Topar, M. Wysocka, G. Trinchieri, A. Enk, R. M. Steinman, N. Romani, and G. Schuler. 1996. Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-γ production by T helper 1 cells. Eur. J. Immunol. 26:659.
49. Steinman, R. M., and J. W. Young. 1991. Signals arising from antigen-presenting cells. Curr. Opin. Immunol. 3:361.
50. Inaba, K., J. P. Metlay, M. T. Crowley, and R. M. Steinman. 1990. Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific. MHC-restricted T cells in situ. J. Exp. Med. 172:631.
51. Macatonia, S. E., P. M. Taylor, S. C. Knight, and B. A. Askonas. 1989. Primary stimulation by dendritic cells induces antiviral proliferative and cytotoxic T cell responses in vitro. J. Exp. Med. 169:1255.
52. Ojcius, D. M., Y. Bravo de Alba, J. M. Kanellopoulos, R. A. Hawkins, K. A. Kelly, R. G. Rank, and A. Dautry-Varsat. 1998. Internalization of Chlamydia by dendritic cells and stimulation of Chlamydia-specific T cells. J. Immunol. 160:12970.
53. King, P. D., M. A. A. Ibrahim, and D. R. Katz. 1993 Adhesion molecules: co-stimulators and co-mitogens in dendritic cell-T cell interaction. Adv. Exp. Med. Biol. 329-53.
54. Jenkins, M. K., D. R. DeSilva, J. G. Johnson, and S. D. Norton. 1993. Costimulating factors and signals relevant for antigen presenting cell function. Adv. Exp. Med. Biol. 329-87.